Elon Musk’s Neuralink to implant brain chip that treats blindness for the first time in 2025

Neuralink's Blindsight Chip: Elon Musk's Neuralink plans to implant its sight-restoring chip, Blindsight, into a human patient in H2 2025, aiming to help individuals with total blindness by directly stimulating the visual cortex. The device has received FDA breakthrough designation and is expected to initially provide low-resolution vision that could eventually surpass natural sight.

Concerns and Comparisons: Experts have raised concerns about the hype surrounding Blindsight, noting that similar technologies have failed in the past, and demand more transparency regarding its development. Unlike other retinal implants, Blindsight targets the brain directly, which may offer advantages for those born blind, but skepticism remains regarding its effectiveness and the potential impact of exaggerated claims on clinical trials.